Risk factors of bronchial dehiscence after primary lung transplantation.
Masashi FurukawaErnest G ChanMatthew R MorrellJohn P RyanRyan M RivosecchiCarlo J IasellaElizabeth A LendermonJoseph M PilewskiPablo G SanchezPublished in: Journal of cardiac surgery (2022)
Based on our analysis, patients that underwent our basiliximab induction protocol for lung transplantation experienced a higher rate of postoperative bronchial dehiscence when compared with patients who receive alemtuzumab induction. We believe this may be associated with a higher steroid exposure in this population. Additional studies are necessary to further characterize the relationship between different induction protocols and bronchial dehiscence following transplantation.